APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
a study on Solid Tumor Cancer, General Kidney Cancer Stomach Cancer Gastroesophageal Junction Adenocarcinoma Gastroesophageal Junction Cancer Non-Small Cell Lung Cancer Lung Cancer Brain Tumor Astrocytoma Glioblastoma Glioma
Solid Tumor, Advanced Cancer, Renal Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, NSCLC, Lung Cancer, Brain Tumor, Glioblastoma Multiforme, Advanced Solid Tumor, Relapsed Solid Tumor, Recurrent Solid Tumor, cMet exon 14 skipping, cMet fusion, Neoplasms, Lung Neoplasms, Glioblastoma, Kidney Neoplasms, APL-101 Oral Capsules
Lead Scientist at UCSF
- Rahul Aggarwal
I am a Medical Oncologist within the Division of Hematology/Oncology at the University of California San Francisco. My clinical practice focuses on patients with advanced solid tumor malignancies with a particular emphasis on genitourinary malignancies including prostate, kidney, bladder, and testicular cancer. I serve as the Co-Leader for the GU Medical Oncology program at UCSF.